These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3492500)
1. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha. Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500 [TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine. Stromberg K; Hudgins WR Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543 [TBL] [Abstract][Full Text] [Related]
3. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals. Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653 [TBL] [Abstract][Full Text] [Related]
4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020 [TBL] [Abstract][Full Text] [Related]
5. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors. Hudgins WR; Orth DN; Stromberg K Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897 [TBL] [Abstract][Full Text] [Related]
6. Multiplicity of transforming growth factors in human malignant effusions. Seo MK; Lynch KE; Podolsky DK Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891 [TBL] [Abstract][Full Text] [Related]
7. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A. Yamada Y; Serrero G J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884 [TBL] [Abstract][Full Text] [Related]
8. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Ethier SP; Langton BC; Dilts CA Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580 [TBL] [Abstract][Full Text] [Related]
9. Presence of growth factors in human pituitary. Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857 [TBL] [Abstract][Full Text] [Related]
10. [Growth factors produced by rat glioma cells: activities of transforming growth factors]. Kanno H; Shinonaga M; Kuwabara T; Umeda M No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559 [TBL] [Abstract][Full Text] [Related]
11. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor. Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622 [TBL] [Abstract][Full Text] [Related]
12. Purification and biological properties of type beta transforming growth factor from mouse transformed cells. Fernandez-Pol JA; Klos DJ; Grant GA Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281 [TBL] [Abstract][Full Text] [Related]
14. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients. Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705 [TBL] [Abstract][Full Text] [Related]
15. Production of transforming growth factors by human colon cancer lines. Coffey RJ; Shipley GD; Moses HL Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610 [TBL] [Abstract][Full Text] [Related]
16. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary. Riss TL; Sirbasku DA J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041 [TBL] [Abstract][Full Text] [Related]
17. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218 [TBL] [Abstract][Full Text] [Related]
18. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Korc M; Haussler CA; Trookman NS Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713 [TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells. Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production. Abdullah NA; Torres BA; Basu M; Johnson HM J Immunol; 1989 Jul; 143(1):113-7. PubMed ID: 2499624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]